SFM
EVOK

Sphera Funds Management’s Evoke Pharma EVOK Stock Holding History

Sphera Funds Management’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-9,798
Closed -$3.5M – 112
2018
Q4 		$3.5M Hold
9,798
– – 0.39% 58
2018
Q3 		$4.21M Hold
9,798
– – 0.48% 60
2018
Q2 		$3.53M Buy
9,798
+7,063
+258% +$2.65M 0.49% 65
2018
Q1 		$819K Sell
2,735
-2,606
-49% -$857K 0.12% 88
2017
Q4 		$1.74M Buy
5,341
+1,376
+35% +$570K 0.2% 101
2017
Q3 		$1.91M Buy
3,965
+493
+14% +$190K 0.27% 87
2017
Q2 		$1.28M Hold
3,472
– – 0.22% 102
2017
Q1 		$1.55M Buy
+3,472
New +$1.42M 0.3% 81

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sphera Funds Management's EVOK Position: Q1 2019 in Review

Sphera Funds Management sold out of Evoke Pharma (EVOK) in Q1 2019, closing a stake of 9,798 shares — an estimated $3.5M sold.

Sphera Funds Management first reported a position in EVOK in Q1 2017 and held it in 8 quarters. The position peaked at $4.21M in Q3 2018. 22 funds tracked by Wall St. Rank hold EVOK as of Q1 2019.

  • Sphera Funds Management reported no remaining Evoke Pharma position as of Q1 2019 after selling out during the quarter.
  • Sphera Funds Management sold 9,798 Evoke Pharma shares in Q1 2019, an estimated $3.5M.
  • Sphera Funds Management first reported a position in Evoke Pharma in Q1 2017 and held it in 8 quarters.
  • Sphera Funds Management's Evoke Pharma position peaked at $4.21M in Q3 2018.
  • 22 funds tracked by Wall St. Rank held Evoke Pharma as of Q1 2019.

Based on Sphera Funds Management's 13F filing for Q1 2019, filed 15 May 2019.